64 related articles for article (PubMed ID: 21298495)
1. Association of Genomic Instability with HbA1c levels and Medication in Diabetic Patients.
Grindel A; Brath H; Nersesyan A; Knasmueller S; Wagner KH
Sci Rep; 2017 Feb; 7():41985. PubMed ID: 28150817
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in the use of metformin: can treating diabetes prevent breast cancer?
Hatoum D; McGowan EM
Biomed Res Int; 2015; 2015():548436. PubMed ID: 25866793
[TBL] [Abstract][Full Text] [Related]
3. TNM cancer staging: can it help develop a novel staging system for type 2 diabetes?
Dar MS; Bég SA
Diabetes Metab Syndr Obes; 2018; 11():845-853. PubMed ID: 30568472
[TBL] [Abstract][Full Text] [Related]
4. [Systematic review of cancer risk in diabetes mellitus].
Noto H
Nihon Rinsho; 2012 Jul; 70 Suppl 5():542-5. PubMed ID: 23156455
[No Abstract] [Full Text] [Related]
5. Demystifying the Relationship Between Metformin, AMPK, and Doxorubicin Cardiotoxicity.
Singh M; Nicol AT; DelPozzo J; Wei J; Singh M; Nguyen T; Kobayashi S; Liang Q
Front Cardiovasc Med; 2022; 9():839644. PubMed ID: 35141304
[TBL] [Abstract][Full Text] [Related]
6. Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways.
Esparza-López J; Alvarado-Muñoz JF; Escobar-Arriaga E; Ulloa-Aguirre A; de Jesús Ibarra-Sánchez M
BMC Cancer; 2019 Jul; 19(1):728. PubMed ID: 31337349
[TBL] [Abstract][Full Text] [Related]
7. Stat3-positive tumor cells contribute to vessels neoformation in primary central nervous system lymphoma.
Ruggieri S; Tamma R; Resta N; Albano F; Coccaro N; Loconte D; Annese T; Errede M; Specchia G; Senetta R; Cassoni P; Ribatti D; Nico B
Oncotarget; 2017 May; 8(19):31254-31269. PubMed ID: 28415725
[TBL] [Abstract][Full Text] [Related]
8. Increase in apoptosis by combination of metformin with silibinin in human colorectal cancer cells.
Tsai CC; Chuang TW; Chen LJ; Niu HS; Chung KM; Cheng JT; Lin KC
World J Gastroenterol; 2015 Apr; 21(14):4169-77. PubMed ID: 25892866
[TBL] [Abstract][Full Text] [Related]
9. Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders.
Gandini S; Puntoni M; Heckman-Stoddard BM; Dunn BK; Ford L; DeCensi A; Szabo E
Cancer Prev Res (Phila); 2014 Sep; 7(9):867-85. PubMed ID: 24985407
[TBL] [Abstract][Full Text] [Related]
10. Metformin inhibits the IL-6-induced epithelial-mesenchymal transition and lung adenocarcinoma growth and metastasis.
Zhao Z; Cheng X; Wang Y; Han R; Li L; Xiang T; He L; Long H; Zhu B; He Y
PLoS One; 2014; 9(4):e95884. PubMed ID: 24789104
[TBL] [Abstract][Full Text] [Related]
11. Metformin reverses multidrug resistance and epithelial-mesenchymal transition (EMT) via activating AMP-activated protein kinase (AMPK) in human breast cancer cells.
Qu C; Zhang W; Zheng G; Zhang Z; Yin J; He Z
Mol Cell Biochem; 2014 Jan; 386(1-2):63-71. PubMed ID: 24096736
[TBL] [Abstract][Full Text] [Related]
12. United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. United Kingdom Prospective Diabetes Study Group.
Ann Intern Med; 1998 Feb; 128(3):165-75. PubMed ID: 9454524
[TBL] [Abstract][Full Text] [Related]
13. Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes.
Blonde L; Klein EJ; Han J; Zhang B; Mac SM; Poon TH; Taylor KL; Trautmann ME; Kim DD; Kendall DM
Diabetes Obes Metab; 2006 Jul; 8(4):436-47. PubMed ID: 16776751
[TBL] [Abstract][Full Text] [Related]
14. Metformin and cancer: new applications for an old drug.
Kourelis TV; Siegel RD
Med Oncol; 2012 Jun; 29(2):1314-27. PubMed ID: 21301998
[TBL] [Abstract][Full Text] [Related]
15. [Diabetes and cancer risk: oncologic considerations].
Rosta A
Orv Hetil; 2011 Jul; 152(29):1144-55. PubMed ID: 21712179
[TBL] [Abstract][Full Text] [Related]
16. Familial diabetes is associated with reduced risk of cancer in diabetic patients: a possible role for metformin.
Berstein LM; Boyarkina MP; Teslenko SY
Med Oncol; 2012 Jun; 29(2):1308-13. PubMed ID: 21298495
[TBL] [Abstract][Full Text] [Related]
17. Association between hepatocellular carcinoma and type 2 diabetes mellitus in Italy: potential role of insulin.
Donadon V; Balbi M; Casarin P; Vario A; Alberti A
World J Gastroenterol; 2008 Oct; 14(37):5695-700. PubMed ID: 18837086
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
